| 000 | 01740 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250518000813.0 | ||
| 264 | 0 | _c20191224 | |
| 008 | 201912s 0 0 eng d | ||
| 022 | _a1442-2050 | ||
| 024 | 7 |
_a10.1093/dote/doy080 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTian, D | |
| 245 | 0 | 0 |
_aNeoadjuvant chemotherapy with irinotecan and nedaplatin in a single cycle followed by esophagectomy on cT4 resectable esophageal squamous cell carcinoma: a prospective nonrandomized trial for short-term outcomes. _h[electronic resource] |
| 260 |
_bDiseases of the esophagus : official journal of the International Society for Diseases of the Esophagus _cMar 2019 |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadministration & dosage |
| 650 | 0 | 4 | _aChemotherapy, Adjuvant |
| 650 | 0 | 4 |
_aEsophageal Neoplasms _xmortality |
| 650 | 0 | 4 |
_aEsophageal Squamous Cell Carcinoma _xmortality |
| 650 | 0 | 4 |
_aEsophagectomy _xmethods |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIrinotecan _xadministration & dosage |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNeoadjuvant Therapy _xmethods |
| 650 | 0 | 4 |
_aOrganoplatinum Compounds _xadministration & dosage |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aZhang, L | |
| 700 | 1 | _aWang, Y | |
| 700 | 1 | _aChen, L | |
| 700 | 1 | _aZhang, K-P | |
| 700 | 1 | _aZhou, Y | |
| 700 | 1 | _aWen, H-Y | |
| 700 | 1 | _aFu, M-Y | |
| 773 | 0 |
_tDiseases of the esophagus : official journal of the International Society for Diseases of the Esophagus _gvol. 32 _gno. 3 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/dote/doy080 _zAvailable from publisher's website |
| 999 |
_c28867254 _d28867254 |
||